In this study, a triad of type I IFN-signaling pathway genes, STAT1, ISG15, and IFIT1, formed a pan-tumor-type negative prognostic factor, and a broader seven-gene cluster established negative prognostic criteria for treatment-resistant breast cancer. This evidence concerns the gene STAT1 and neoplasm.